Skip to main content
SpringerLink
Log in

Incontinence

  • Chapter
  • First Online:
Neuro-Urology

  • 847 Accesses

Abstract

Normal micturition is a complex process that is controlled by the neural integration between the central and peripheral nervous systems to coordinate sympathetic, parasympathetic, and somatic nervous system activity to allow for normal micturition and urinary continence. Any neurological or mechanical abnormalities in this circuit may result in lower urinary tract dysfunction. Various neurological conditions can cause neurogenic lower urinary tract dysfunction. The degree of dysfunction and severity of symptoms are highly dependent on the nature, location, and extent of the neurological disease, and depending on the level of the injury, different types of urinary incontinence can be experienced.

Neurogenic lower urinary tract dysfunction and urinary incontinence negatively affect the social, psychological, financial, and quality of life of neurological patients. Treatment is aimed at protecting the upper urinary tracts and improving quality of life and should follow a pathway starting with conservative and medical therapy and then progressing to minimally invasive surgery with major surgery left as a last resort. The main aim of treatment in NLUTD is to individualize and tailor it to the needs of the patient.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 159.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Del Popolo G, Panariello G, Del Croso F, et al. Diagnosis and therapy for neurogenic bladder dysfunctions in multiple sclerosis patients. Neurol Sci. 2008;29(suppl 4):S352–5. https://doi.org/10.1007/s10072-008-1042-y.

    Article  PubMed  Google Scholar 

  2. Kaplan SA, Chancellor MB, Blaivas JG. Bladder and sphincter behavior in patients with spinal cord lesions. J Urol. 1991;146:113–7.

    Article  CAS  PubMed  Google Scholar 

  3. Dorsher PT, McIntosh PM. Neurogenic bladder [published online February 8, 2012]. Adv Urol. 2012;2012:816274. https://doi.org/10.1155/2012/816274.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Lansang RS, Krouskop AC. Bladder management. In: Massagli TL, et al., editors. eMedicine; 2004.

    Google Scholar 

  5. Verhoef M, Lurvink M, Barf HA, et al. High prevalence of incontinence among young adults with spina bifida: description, prediction and problem perception. Spinal Cord. 2005;43:331–40.

    Article  CAS  PubMed  Google Scholar 

  6. Blok B, Pannek J, Castro-Diaz D et al. EAU Guidelines on Neuro-Urology. 2015. http://uroweb.org/guideline/neuro-urology. Accessed Mar 2015.

  7. Manack A, Mostko SP, Haag-Molkenteller, et al. Epidemiology and healthcare utilization of neurogenic bladder patients in a US claims database. NeurourolUrodyn. 2011;30:395–401.

    Google Scholar 

  8. Linsenmeyer TA, Culkin D. APS recommendations for the urological evaluation of patients with spinal cord injury. J Spinal Cord Med. 1999;22:139–42.

    Article  CAS  PubMed  Google Scholar 

  9. Griffiths D, Derbyshire S, Stenger A, Resnick N. Brain control of normal and overactive bladder. J Urol. 2005;174(5):1862–7.

    Article  PubMed  Google Scholar 

  10. Panicker JN, de Seze M, Fowler CJ, et al. Rehabilitation in practice: neurogenic lower urinary tract dysfunction and its management. Clin Rehabil. 2010;24:579–89.

    Article  PubMed  Google Scholar 

  11. Fowler CJ, Griffiths D, de Groat WC. The neural control of micturition. Nat Rev Neurosci. 2008;9:453–66.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Ouslander JG. Management of overactive bladder. N Engl J Med. 2004;350(8):786–99.

    Article  CAS  PubMed  Google Scholar 

  13. Al-Shukri SA. Neurogenic bladder-assessment, investigation, and treatment. Eur Urol Rev. 2012;7:55–60.

    Google Scholar 

  14. Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U, et al. The standardisation of terminology of lower urinary tract function: report from the standardisation sub-committee of the inter-national continence society. NeurourolUrodyn. 2002;21(2):167–78.

    Google Scholar 

  15. Haylen BT, de Ridder D, Freeman RM, Swift SE, Berghmans B, Lee J, et al. An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction. NeurourolUrodyn. 2010;29(1):4–20.

    Google Scholar 

  16. Dursun M, Otunctemur A, Ozbek E, Sahin S, Besiroglu H, Koklu I. Stress urinary incontinence and visceral adipose index: a new risk parameter. Int Urol Nephrol. 2014;46(12):2297–300.

    Article  PubMed  Google Scholar 

  17. Vissers D, Neels H, Vermandel A, De Wachter S, Tjalma WA, Wyndaele JJ, et al. The effect of non-surgical weight loss interventions on urinary incontinence in overweight women: a systematic review and meta-analysis. Obes Rev. 2014;15(7):610–7.

    Article  CAS  PubMed  Google Scholar 

  18. Lenherr SM, Clemens JQ, Braffett BH, Dunn RL, Cleary PA, Kim C, et al. Glycaemic control and risk of incident urinary incontinence in women with type 1 diabetes: results from the Diabetes Control and Complications Trial and Epidemiology of Diabetes Interventions and Complications study (DCCT/EDIC). Diabet Med. 2016;33(11):1528–35.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Ahn KS, Hong HP, Kweon HJ, Ahn AL, Oh EJ, Choi JK, et al. Correlation between overactive bladder syndrome and obsessive compulsive disorder in women. Korean J Fam Med. 2016;37(1):25–30.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Walid MS. Prevalence of urinary incontinence in female residents of American nursing homes and association with neuropsychiatric disorders. J Clin Med Res. 2009;1(1):37–9.

    PubMed  PubMed Central  Google Scholar 

  21. Nygaard IE, Shaw JM, Bardsley T, Egger MJ. Lifetime physical activity and female stress urinary incontinence. Am J Obstet Gynecol. 2015;213(1):40.e1–10.

    Article  Google Scholar 

  22. Sheyn D, James RL, Taylor AK, Sam-marco AG, Benchek P, Mahajan ST. Tobacco use as a risk factor for reoperation in patients with stress urinary incontinence: a multi-institutional electronic medical record database analysis. Int Urogynecol J. 2015;26(9):1379–84.

    Article  PubMed  PubMed Central  Google Scholar 

  23. DuBeau CE. The continuum of urinary incontinence in an aging population. Geriatrics. 2002;57(Suppl 1):S12–7.

    Google Scholar 

  24. Jensen JK, Nielsen FR Jr, Ostergard DR. The role of patient history in the diagnosis of urinary incontinence. Obstet Gynecol. 1994;83(5 Pt 2):904–10.

    PubMed  CAS  Google Scholar 

  25. Schurch B, Schmid DM, Karsenty G, Reitz A. Can neurologic examination predict type of detrusor sphincter-dyssynergia in patients with spinal cord injury? Urology. 2005;65:243–6.

    Article  PubMed  Google Scholar 

  26. Abrams P, Agarwal M, Drake M, et al. A proposed guideline for the urological management of patients with spinal cord injury. BJU Int. 2008;101:989–94.

    Article  PubMed  Google Scholar 

  27. Wyndaele JJ, De Sy WA. Correlation between the findings of a clinical neurological examination and the urodynamic dysfunction in children with myelodysplasia. J Urol. 1985;133:638–40.

    Article  CAS  PubMed  Google Scholar 

  28. Hill TC, Baverstock R, Carlson KV, Estey EP, Gray GJ, Hill DC, Ho C, McGinnis RH, Moore K, Parmar R. Best practices for the treatment and prevention of urinary tract infection in the spinal cord injured population: the Alberta context. Can Urol Assoc J. 2013;7(3- 4):122–30.

    Article  PubMed  PubMed Central  Google Scholar 

  29. Drake MJ. Re: influences on renal function in chronic spinal cord injured patients. J Urol. 2001;165(6 Pt 1):2006.

    Article  CAS  PubMed  Google Scholar 

  30. Bright E, Cotterill N, Drake M, Abrams P. Developing and validating the international consultation on incontinence questionnaire bladder diary. Eur Urol. 2014;66:294–300.

    Article  PubMed  Google Scholar 

  31. Wyndaele JJ. A critical review of urodynamic investigations in spinal cord injury patients. Paraplegia. 1984;22:138–44.

    PubMed  CAS  Google Scholar 

  32. Nitti VW, Adler H, Combs AJ. The role of urodynamics in the evaluation of voiding dysfunction in men after cerebrovascular accident. J Urol. 1996;155:263–6.

    Article  CAS  PubMed  Google Scholar 

  33. Hamid R, Bycroft J, Arya M, Shah PJ. Screening cystoscopy and biopsy in patients with neuropathic bladder and chronic suprapubic indwelling catheters: is it valid? J Urol. 2003;170:425–7.

    Article  CAS  PubMed  Google Scholar 

  34. Sammer U, Walter M, Knüpfer SC, Mehnert U, Bode-Lesniewska B, Kessler TM. Do we need surveillance Urethro-cystoscopy in patients with neurogenic lower urinary tract dysfunction? PLoS One. 2015;10(10):e0140970.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Lucas MG, Bosch RJ, Burkhard FC, Cruz F, Madden TB, Nambiar AK, et al. EAU guidelines on assessment and nonsurgical management of urinary incontinence. Eur Urol. 2012;62(6):1130–42. Erratum in: Eur Urol. 2013;64(1):e20

    Article  PubMed  Google Scholar 

  36. Bothig R, Hirschfeld S, Thietje R. Quality of life and urological morbidity in tetraplegics with artificial ventilation managed with suprapubic or intermittent catheterisation. Spinal Cord. 2012;50:247–51.

    Article  CAS  PubMed  Google Scholar 

  37. Cameron AP, Wallner LP, Forchheimer MB, et al. Medical and psychosocial complications associated with method of bladder management after traumatic spinal cord injury. Arch Phys Med Rehabil. 2011;92:449–56.

    Article  PubMed  Google Scholar 

  38. Di Benedetto P. Clean intermittent self-catheterization in neuro-urology. Eur J Phys Rehabil Med. 2011;47:651–9.

    PubMed  Google Scholar 

  39. Kochakarn W, Ratana-Olarn K, Lertsithichai P, Roongreungsilp U. Follow-up of long-term treatment with clean intermittent catheterization for neurogenic bladder in children. Asian J Surg. 2004;27:134–6.

    Article  PubMed  Google Scholar 

  40. Gajewski JB, Awad SA. Oxybutynin versus propantheline in patients with multiple sclerosis and detrusor hyperreflexia. J Urol. 1986;135:966–8.

    Article  CAS  PubMed  Google Scholar 

  41. Lee JH, Kim KR, Lee YS, Han SW, Kim KS, Song SH, Baek M, Park K. Efficacy, tolerability, and safety of oxybutynin chloride in pediatricneurogenic bladder with spinal dysraphism: a retrospective, multicenter, observational study. Korean J Urol. 2014;55(12):828–33.

    Article  PubMed  PubMed Central  Google Scholar 

  42. Mazo EB, Krivoborodov GG, Shkol’nikov ME, Babanina GA, Kozyrev SV, Korshunov ES. Trospium chloride in the treatment of idiopathic and neurogenic detrusor overactivity. Urologiia. 2005:56–9.

    Google Scholar 

  43. Mazo EB, Babanina GA. Trospium chloride (spasmex) in the treatment of lower urinary tract symptoms in patients with neurogenic hyperactive urinary bladder caused by vertebrogenic lesions. Urologiia. 2007:15–9.

    Google Scholar 

  44. van Rey F, Heesakkers J. Solifenacin in multiple sclerosis patients with overactive bladder: a prospective study. Adv Urol. 2011;2011:834753.

    PubMed  PubMed Central  Google Scholar 

  45. Krebs J, Pannek J. Effects of Solifenacin in patients with neurogenic detrusor overactivity as a result of spinal cord lesion. Spinal Cord. 2013;51:306–9.

    Article  CAS  PubMed  Google Scholar 

  46. Nicholas RS, Friede T, Hollis S, Young CA. Anticholinergics for urinary symptoms in multiple sclerosis. Cochrane Database Syst Rev. 2009;(1):CD004193.

    Google Scholar 

  47. Wöllner J, Pannek J. Initial experience with the treatment of neurogenic detrusor overactivity with a new beta-3 agonist (Mirabegron) in patients with spinal cord injury. Spinal Cord. 2016;54(1):78–82.

    Article  PubMed  Google Scholar 

  48. Stankovich E, Borisov VV, Demina TL. Tamsulosin in the treatment of detrusor sphincter dyssynergia of the urinary bladder in patients with multiple sclerosis. Urologia. 2004:48–51.

    Google Scholar 

  49. Abrams P, Amarenco G, Bakke A, Buczynski A, Castro-Diaz D, Harrison S, et al. Tamsulosin: efficacy and safety in patients with neurogenic lower urinary tract dysfunction due to suprasacral spinal cord injury. J Urol. 2003;170:1242–51.

    Article  PubMed  Google Scholar 

  50. Karsenty G, Denys P, et al. Botulinum toxin A (Botox) intradetrusor injections in adults with neurogenic detrusor overactivity/neurogenic overactive bladder: a systematic literature review. Eur Urol. 2008;53(2):275–7.

    Article  CAS  PubMed  Google Scholar 

  51. Apostolidis A, Dasgupta P, Denys P, Elneil S, Fowler CJ, Giannantoni A, et al. Recommendations on the use of botulinum toxin in the treatment of lower urinary tract disorders and pelvic floor dysfunctions: a European consensus panel report. Eur Urol 2009;55:100-120.

    Google Scholar 

  52. Mangera A, Andersson KE, Apostolidis A, Chapple C, Dasgupta P, Giannantoni A, et al. Contemporary management of lower urinary tract disease with botulinum toxin A: a systematic review of botox (onabotulinumtoxinA) and dysport (abobotulinumtoxinA). Eur Urol. 2011;60(4):784–95.

    Article  CAS  PubMed  Google Scholar 

  53. Duthie JB, Vincent M, Herbison GP, Wilson DI, Wilson D. Botulinum toxin injections for adults with overactive bladder syndrome. Cochrane Database Syst Rev. 2011;12:CD005493.

    Google Scholar 

  54. Mangera A, Apostolidis A, Andersson KE, Dasgupta P, Giannantoni A, Roehrborn C, et al. An updated systematic review and statistical comparison of standardised mean outcomes for the use of botulinum toxin in the management of lower urinary tract disorders. Eur Urol. 2014;65(5):981–90.

    Article  CAS  PubMed  Google Scholar 

  55. Zhang R, Xu Y, Yang S, Liang H, Zhang Y, Liu Y. OnabotulinumtoxinA for neurogenic detrusor overactivity and dose differences: a systematic review. Int Braz J Urol. 2015;41(2):207–19.

    Article  PubMed  PubMed Central  Google Scholar 

  56. Schurch B, de Seze M, Denys P, Chartier- Kastler E, Haab F, Everaert K, et al. Botulinum toxin type a is a safe and effective treatment for neurogenic urinary incontinence: results of a single treatment, randomized, placebo controlled 6-month study. J Urol. 2005;174(1):196–200.

    Article  CAS  PubMed  Google Scholar 

  57. Giannantoni A, Di Stasi SM, Stephen RL, Bini V, Konstantini E, Porena M. Intravesical resiniferatoxin versus botulinum-A toxin injections for neurogenic detrusor overactivity: a prospective randomized study. J Urol. 2004;172(1):240–3.

    Article  CAS  PubMed  Google Scholar 

  58. de Seze M, Petit H, Gallien P, de Seze MP, Joseph PA, Mazaux JM, et al. Botulinum a toxin and detrusor sphincter dyssynergia: a double blind lidocaine-controlled study in 13 patients with spinal cord disease. Eur Urol. 2002;42(1):56–62.

    Article  PubMed  Google Scholar 

  59. Gallien P, Reymann JM, Amarenco G, Nicolas B, de Seze M, Bellissant E. Placebo controlled, randomised, double blind study of the effects of botulinum A toxin on detrusor sphincter dyssynergia in multiple sclerosis patients. J Neurol Neurosurg Psychiatry. 2005;76(12):1670–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  60. van Kerrebroeck PE, van Voskuilen AC, Heesakkers JP, Lycklama a Nijholt AA, Siegel S, Jonas U, et al. Results of sacral neuromodulation therapy for urinary voiding dysfunction: outcomes of a prospective, worldwide clinical study. J Urol. 2007;178:2029–34.

    Article  PubMed  Google Scholar 

  61. de Seze M, Raibaut P, Gallien P, et al. Transcutaneous posterior tibial nerve stimulation for treatment of the overactive bladder syndrome in multiple sclerosis: results of a multicenter prospective study. NeurourolUrodyn. 2011;30:306–11.

    Google Scholar 

  62. Hagerty JA, Richards I, Kaplan WE. Intravesical electrotherapy for neurogenic bladder dysfunction: a 22-year experience. J Urol. 2007;178:1680–3.

    Article  PubMed  Google Scholar 

  63. Vodusek DB, Light JK, Libby JM. Detrusor inhibition induced by stimulation of pudendal nerve afferents. NeurourolUrodyn. 1986;5:381–90.

    Google Scholar 

  64. Chartier-Kastler EJ, Ruud Bosch JL, Perrigot M, Chancellor MB, Richard F, Denys P. Long term results of sacral nerve stimulation (S3) for the treatment of neurogenic refractory urge incontinence related to detrusor hyperreflexia. J Urol. 2000;164:1476–80.

    Article  CAS  PubMed  Google Scholar 

  65. Bosch RJL, Groen J. Neuromodulation: urodynamic effects of sacral (S3) spinal nerve stimulation in patients with detrusor instability or detrusor hyperflexia. Behav Brain Res. 1998;92:141–50.

    Article  CAS  PubMed  Google Scholar 

  66. Zvara P, Sahi S, Hassouna MM. An animal model for the neuromodulation of neurogenic bladder dysfunction. Br J Urol. 1998;82:267–71.

    Article  CAS  PubMed  Google Scholar 

  67. Kessler TM, Burkhard FC, Z’Brun S, Stibal A, Studer UE, Hess CW, et al. Effect of thalamic deep brain stimulation on lower urinary tract function. Eur Urol. 2008;53:607–12.

    Article  PubMed  Google Scholar 

  68. Blok BF, Groen J, Bosch JL, Veltman DJ, Lammertsma AA. Different brain effects during chronic and acute sacral neuromodulation in urge incontinent patients with implanted neurostimulators. BJU Int. 2006;98:1238–43.

    Article  Google Scholar 

  69. Colli J, Lloyd LK. Bladder neck closure and suprapubic catheter placement as definitive management of neurogenic bladder. J Spinal Cord Med. 2011;34(3):273–7.

    Article  PubMed  PubMed Central  Google Scholar 

  70. Westney OL, Lee JT, McGuire EJ, Palmer JL, Cespedes RD, Amundsen CL. Long-term results of Ingelman-Sundberg denervation procedure for urge incontinence refractory to medical therapy. J Urol. 2002;168:1044–7.

    Article  PubMed  Google Scholar 

  71. Cespedes RD, Cross CA, McGuire EJ. Modified Ingelman-Sundberg bladder denervation procedure for intractable urge incontinence. J Urol. 1996;156:1744–7.

    Article  CAS  PubMed  Google Scholar 

  72. Ross JC, Damanski M, Giddons N. Resection of the external urethral sphincter in the paraplegic- preliminary report. J Urol. 1958;79:742–6.

    Article  CAS  PubMed  Google Scholar 

  73. Chancellor MB, Gajewski J, Ackman CF, Appell RA, Bennett J, Binard J, et al. Long-term follow up of the North American multicenter UroLume trial for the treatment of external detrusor- sphincter dyssynergia. J Urol. 1999;161:1545–50.

    Article  CAS  PubMed  Google Scholar 

  74. Ninkovic M, Stenzl A, Schwabegger A, Bartsch G, Prosser R, Ninkovic M. Free neurovascular transfer of latissimus dorsi muscle for the treatment of bladder acontractility: II. Clinical results. J Urol. 2003;169:1379–83.

    Article  CAS  PubMed  Google Scholar 

  75. Gundeti MS, Acharya SS, Zagaja GP, Shalhav AL. Paediatric robotic-assisted laparoscopic augmentation ileocystoplasty and Mitrofanoff appendicovesicostomy (RALIMA): feasibility of and initial experience with the University of Chicago technique. BJU Int. 2011;107:962–9.

    Article  PubMed  Google Scholar 

  76. Ehrlich RM, Gershman A. Laparoscopic seromyotomy (auto-augmentation) for non-neurogenic neurogenic bladder in a child: initial case report. Urology. 1993;42:175–8.

    Article  CAS  PubMed  Google Scholar 

  77. Mollard P, Gauriau L, Bonnet JP, Mure PY. Continent cystostomy (Mitrofanoff’s procedure) for neurogenic bladder in children and adolescent (56 cases: long-term results). Eur J Pediatr Surg. 1997;7:34–7.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Urology, King Fahad Specialist Hospital, Dammam, Saudi Arabia

    Riyad Taher Al-Mousa

  2. Bristol Urological Institute, Southmead Hospital, Bristol, UK

    Hashim Hashim

Authors
  1. Riyad Taher Al-Mousa
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hashim Hashim
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Urology, Vanderbilt University Medical Center, Nashville, TN, USA

    Roger Dmochowski

  2. Department of Urology, Radboud University, Nijmegen, The Netherlands

    John Heesakkers

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG, part of Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Al-Mousa, R.T., Hashim, H. (2018). Incontinence. In: Dmochowski, R., Heesakkers, J. (eds) Neuro-Urology. Springer, Cham. https://doi.org/10.1007/978-3-319-90997-4_14

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-90997-4_14

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-90995-0

  • Online ISBN: 978-3-319-90997-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation